{"id":"https://openalex.org/W307403642","doi":"https://doi.org/10.21236/ada404563","title":"Secretory Anti-erbB-2 scFv Gene Therapy for Breast Cancer","display_name":"Secretory Anti-erbB-2 scFv Gene Therapy for Breast Cancer","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W307403642","doi":"https://doi.org/10.21236/ada404563","mag":"307403642"},"language":"en","primary_location":{"id":"doi:10.21236/ada404563","doi":"https://doi.org/10.21236/ada404563","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada404563","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},"volume":null,"type":"report","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022987623","display_name":"David T. Curiel","orcid":"https://orcid.org/0000-0003-3802-6014","observed_orcids":["https://orcid.org/0000-0003-3802-6014"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David T. Curiel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5022987623"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.7519999742507935,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.1679999977350235,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.06350000202655792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/single-chain-antibody","display_name":"single-chain antibody","score":0.7020000219345093},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.7480000257492065},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/adenovirus-vectors","display_name":"adenoviral vector","score":0.8539999723434448},{"id":"https://openalex.org/keywords/in-vivo-gene-transfer","display_name":"in vivo gene delivery","score":0.9309999942779541},{"id":"https://openalex.org/keywords/targeted-gene-therapy","display_name":"targeted gene therapy","score":0.6970000267028809},{"id":"https://openalex.org/keywords/tumor-suppression","display_name":"tumor suppression","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6558353900909424},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.5675546526908875},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5261035561561584},{"id":"https://openalex.org/C111599444","wikidata":"https://www.wikidata.org/wiki/Q213901","display_name":"Genetic enhancement","level":3,"score":0.5140929818153381},{"id":"https://openalex.org/C2779251935","wikidata":"https://www.wikidata.org/wiki/Q5385089","display_name":"ErbB","level":3,"score":0.4934164583683014},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44365644454956055},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35267406702041626},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.31416603922843933},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27110975980758667},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1684596836566925}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21236/ada404563","doi":"https://doi.org/10.21236/ada404563","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada404563","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},{"id":"pmh:ADA404563","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA404563","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2035422010","https://openalex.org/W2001723579","https://openalex.org/W2008024194","https://openalex.org/W2056565619","https://openalex.org/W2069020746","https://openalex.org/W1967334867","https://openalex.org/W133355765","https://openalex.org/W2022647282","https://openalex.org/W2050314327","https://openalex.org/W2096214890"],"abstract_inverted_index":{"Single":[0],"chain":[1],"antibodies":[2],"(scFv)":[3],"represent":[4],"powerful":[5,153],"interventional":[6],"agents":[7,19],"for":[8,63,91,166],"the":[9,33,89,92,111,129],"achievement":[10,34],"of":[11,17,29,35,40,81,123,128,142,169],"targeted":[12,173],"therapeutics.":[13],"The":[14,68],"practical":[15],"utility":[16],"these":[18,46],"have":[20,49,164],"been":[21],"limited,":[22],"however,":[23],"by":[24,65,121],"difficulties":[25],"related":[26],"to":[27,53,73,100,155,172],"production":[28],"recombinant":[30],"scFv":[31,41,55,60,70,94,113,143],"and":[32,37,76,133],"effective":[36,140,157],"sustained":[38],"levels":[39],"in":[42,56,84,134],"situ.":[43],"To":[44],"circumvent":[45],"limitations,":[47],"we":[48],"developed":[50],"an":[51,102],"approach":[52],"express":[54],"vivo.":[57],"An":[58],"anti-erbB2":[59,104,112],"was":[61],"engineered":[62],"secretion":[64],"eukaryotic":[66],"cells.":[67],"secreted":[69,126],"could":[71,96],"bind":[72],"its":[74],"target":[75,98],"specifically":[77],"suppress":[78],"cell":[79],"growth":[80],"erbB2-positive":[82],"cells":[83,99],"vitro.":[85],"Adenoviral":[86],"vectors":[87],"expressing":[88],"cDNA":[90],"secretory":[93],"likewise":[95],"induce":[97],"produce":[101],"anti-tumor":[103,118,130],"scFv.":[105],"In":[106,146],"vivo":[107,135,147],"gene":[108,148],"transfer":[109,149],"via":[110,137],"encoding":[114],"adenovirus":[115],"also":[116],"showed":[117],"effects.":[119],"Thus,":[120],"virtue":[122],"engineering":[124],"a":[125,152,167],"version":[127],"anti-erbB-2":[131],"scFv,":[132],"expression":[136],"adenoviral":[138],"vector,":[139],"concentrations":[141],"were":[144],"achieved.":[145],"clearly":[150],"represents":[151],"means":[154],"realize":[156],"scFv-based":[158],"approaches.":[159,175],"This":[160],"method":[161],"will":[162],"likely":[163],"applicability":[165],"range":[168],"disorders":[170],"amenable":[171],"therapeutic":[174]},"counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2016-06-24T00:00:00"}